12-2605705-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000719.7(CACNA1C):​c.3075C>T​(p.Ala1025Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000731 in 1,613,918 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000046 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000076 ( 2 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.52

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C-AS3 (HGNC:40117): (CACNA1C antisense RNA 3)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 12-2605705-C-T is Benign according to our data. Variant chr12-2605705-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 527118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.52 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000046 (7/152290) while in subpopulation SAS AF = 0.00125 (6/4818). AF 95% confidence interval is 0.000542. There are 1 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.3225C>T p.Ala1075Ala synonymous_variant Exon 25 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.3240C>T p.Ala1080Ala synonymous_variant Exon 25 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.3135C>T p.Ala1045Ala synonymous_variant Exon 25 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.3165C>T p.Ala1055Ala synonymous_variant Exon 24 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.3165C>T p.Ala1055Ala synonymous_variant Exon 24 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.3165C>T p.Ala1055Ala synonymous_variant Exon 24 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.3165C>T p.Ala1055Ala synonymous_variant Exon 24 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.3150C>T p.Ala1050Ala synonymous_variant Exon 25 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.3135C>T p.Ala1045Ala synonymous_variant Exon 25 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.3150C>T p.Ala1050Ala synonymous_variant Exon 25 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.3066C>T p.Ala1022Ala synonymous_variant Exon 24 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.3075C>T p.Ala1025Ala synonymous_variant Exon 24 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*1682C>T non_coding_transcript_exon_variant Exon 22 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*1682C>T 3_prime_UTR_variant Exon 22 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152172
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000915
AC:
23
AN:
251434
AF XY:
0.000125
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000759
AC:
111
AN:
1461628
Hom.:
2
Cov.:
30
AF XY:
0.000100
AC XY:
73
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00102
AC:
88
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000180
AC:
20
AN:
1111814
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152290
Hom.:
1
Cov.:
32
AF XY:
0.0000806
AC XY:
6
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41546
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00125
AC:
6
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000564
Hom.:
0
Bravo
AF:
0.0000264
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Aug 05, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
14
DANN
Benign
0.85
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375813950; hg19: chr12-2714871; API